Completed: 50%
Quest hub:
Prevention & handling of widespread infectious diseases through science and tech, with focus on COVID-19
Welcome!
Visitors, explore and click the tabs from DATA to EVENTS (scroll left on mobile)
What is our purpose with this Quest?
- To create agile, interactive, and complete overviews and roadmaps of the technologies driving progress on handling and preventing COVID-19 and future epidemics, and then help accelerate that progress
How?
- The publicly available databases and roadmaps we create as a community help align all entities working on solutions and identify where to focus efforts and resources for maximum impact
- Enable anyone, even non-technical people, to take action to fight COVID-19 with science, technology, and innovation via our tasks
- Provide an open source pre-projecting platform to nurture ideas and breed innovation for new and improved solutions
- This all leads to making the most of our global resources, collaboration, and impact to accelerate progress on the most ideal, affordable, and sustainable solutions
Want to help?
- Become a Hero and JOIN NOW (is free, takes 10 minutes here and there)
- Join our growing volunteering team of researchers, ambassadors, content creators, communicators, moderators...more info and sign-up HERE
- Spread the word: follow, like, tag, share! Insta LinkedIn FB Twitter
- Show some love via our Support page
Heroes and volunteers, go take action with a Task, be vocal in the Labs, or post in the newsfeed!
Read our community written articles on...
- The current state and future of COVID-19 testing
- Testing tech using saliva and light
- The current state of a COVID-19 vaccine
- COVID-19 Disinfection Innovation
- What happens after on-site testing of COVID-19
Current community goal: Reach 200 followers for this Quest! Expand the Progress Bar above to see the status
Check out our curated list of COVID-19 resources below from our LIBRARY section...
Quest leaderboard
Oct 19, 2020
Solidarity fails to find mortality benefits in four treatments—but the global trial itself wins praise. “We would love to have a drug that works, but it’s better to know if a drug works or not than not to know and continue to use it,” says WHO’s chief scientist, Soumya Swaminathan.
Oct 19, 2020
Countries with international travel restrictions suffered fewer COVID-19 fatalities. Travel restrictions implemented early on in the pandemic have been crucial in slowing the spread of the coronavirus and keeping death rates low. A new study published by Ruud Koopmans, director at the WZB Berlin So
Oct 15, 2020
A 25-year-old man from Nevada and a 42-year-old man in Virginia experienced second bouts of COVID-19 about 2 months after they tested positive the first time. Gene tests show both men had two slightly different strains of the virus, suggesting that they caught the infection twice.
Oct 12, 2020
Since the early days of the coronavirus pandemic, scientists and doctors have warned of airborne transmission of SARS-CoV-2. Finally, in October 2020 -- seven months into the pandemic -- public health agencies have acknowledged the potential of airborne spread. Here's what you should know about airborne transmission of COVID-19.
Oct 12, 2020
Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.
Oct 12, 2020
Several European nations report new daily highs, and hospital cases are rising in France.
Oct 08, 2020
Dozens of case reports have hinted that the coronavirus might trigger the onset of diabetes in people with no history of the disease.
Oct 08, 2020
Primate researchers in the United States have banded together in a push for an ambitious monkey study that would do head-to-head comparisons of the leading COVID-19 vaccine candidates.
Oct 06, 2020
"The CDC cited published reports that demonstrated "limited, uncommon circumstances" in which people with the virus infected others who were more than 6 feet away."
Oct 04, 2020
The precious few molecules that could end the pandemic are hidden by millions that can't. Can AI help find them in time?
Oct 04, 2020
Hologic announced that its Panther Fusion SARS-CoV-2 assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for testing people without symptoms of a COVID-19 infection, according to a press release.
Oct 04, 2020
But scientists are trying to learn more